07:00 , Aug 18, 2014 |  BioCentury  |  Finance

Flagship's fashion

Venture investment models come and go out of fashion, but Flagship Ventures has stuck with its thesis that novel, early stage platform companies with significant disruptive potential are the way to go. And rather than...
07:00 , Sep 19, 2011 |  BioCentury  |  Finance

Planting trees

Planting trees Arboretum Ventures has closed a $140 million third fund that the firm will invest in medical device, diagnostics and healthcare services companies in equal measure. The fund was raised in about eight months and exceeded...
07:00 , Jul 18, 2011 |  BioCentury  |  Finance

Cash for flow

Cash for flow By applying mass spectroscopy to flow cytometry, DVS Sciences Inc. created a "mass cytometer" that could offer drug developers an efficient way of studying intracellular networks and disease state transitions. The company's first...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Company News

Accuri Cytometers, Becton Dickinson deal

Becton Dickinson completed its previously announced acquisition of Accuri for an undisclosed sum. Further terms were not disclosed (see BioCentury, Feb. 14). Accuri Cytometers Inc., Ann Arbor, Mich.   Becton Dickinson and Co. (NYSE:BDX), Franklin Lakes,...
08:00 , Feb 14, 2011 |  BC Week In Review  |  Company News

Accuri Cytometers, Becton Dickinson deal

Becton Dickinson said it will acquire Accuri for an undisclosed sum. Becton said the acquisition of Accuri, which markets personal flow cytometers for research use, will expand its presence in the personal flow cytometer industry...
07:00 , May 17, 2010 |  BC Week In Review  |  Company News

Accuri Cytometers Inc., IncellDx Inc. sales and marketing update

Accuri will supply IncellDx with its Accuri C6 Flow Cytometer for use in combination with IncellDx's HPV OncoTect. IncellDx will market Accuri's cytometers when used with its HPV OncoTect test. The HPV OncoTect E6, E7...